HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Previous close
₹1,541.70
Day range
₹1,492.05 - ₹1,546.15
Year range
₹771.00 - ₹1,830.95
Market cap
423.07B INR
Avg Volume
612.72K
P/E ratio
-
Dividend yield
0.17%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 34.34B | 7.06% |
Operating expense | 18.82B | 11.45% |
Net income | 3.54B | 532.26% |
Net profit margin | 10.32 | 504.71% |
Earnings per share | 12.55 | — |
EBITDA | 6.01B | 26.34% |
Effective tax rate | 24.99% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.20B | 61.94% |
Total assets | 152.35B | -23.85% |
Total liabilities | 67.90B | -33.89% |
Total equity | 84.45B | — |
Shares outstanding | 141.12M | — |
Price to book | 2.58 | — |
Return on assets | — | — |
Return on capital | 12.47% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 3.54B | 532.26% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Wikipedia
Founded
Nov 18, 1977
Website
Employees
14,989
